These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9617982)

  • 1. Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines.
    Cole JO; Levin A; Beake B; Kaiser PE; Scheinbaum ML
    J Clin Psychopharmacol; 1998 Jun; 18(3):231-6. PubMed ID: 9617982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse liability assessment of sibutramine, a novel weight control agent.
    Schuh LM; Schuster CR; Hopper JA; Mendel CM
    Psychopharmacology (Berl); 2000 Jan; 147(4):339-46. PubMed ID: 10672626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction.
    Zannad F; Gille B; Grentzinger A; Bruntz JF; Hammadi M; Boivin JM; Hanotin C; Igau B; Drouin P
    Am Heart J; 2002 Sep; 144(3):508-15. PubMed ID: 12228789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sibutramine. A review of its contribution to the management of obesity.
    McNeely W; Goa KL
    Drugs; 1998 Dec; 56(6):1093-124. PubMed ID: 9878996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1016-24. PubMed ID: 10557021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
    Birkenfeld AL; Schroeder C; Pischon T; Tank J; Luft FC; Sharma AM; Jordan J
    Clin Auton Res; 2005 Jun; 15(3):200-6. PubMed ID: 15944869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
    Thomas GH; Babbs AJ; Chatfield RE; Krülle TM; Widdowson PS; Provost D; McCormack JG
    Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
    Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
    Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE; Crow SJ; Hudson JI; Mitchell JE; Berkowitz RI; Blakesley V; Walsh BT;
    Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sibutramine intake on resting and exercise physiological responses.
    Rotstein A; Inbar O; Vaisman N
    Ann Nutr Metab; 2008; 52(1):17-23. PubMed ID: 18230966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical effect of sibutramine on autonomic cardiovascular regulation.
    Birkenfeld AL; Schroeder C; Boschmann M; Tank J; Franke G; Luft FC; Biaggioni I; Sharma AM; Jordan J
    Circulation; 2002 Nov; 106(19):2459-65. PubMed ID: 12417543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermogenic effects of sibutramine in humans.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Am J Clin Nutr; 1998 Dec; 68(6):1180-6. PubMed ID: 9846844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
    Aronne LJ; Halseth AE; Burns CM; Miller S; Shen LZ
    Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sibutramine on the treatment of obesity in patients with arterial hypertension.
    Faria AN; Ribeiro Filho FF; Lerario DD; Kohlmann N; Ferreira SR; Zanella MT
    Arq Bras Cardiol; 2002 Feb; 78(2):172-80. PubMed ID: 11887193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.